|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter
334
|
Tue, 7/31/07, 2:00 PM - 3:50 PM | CC-Ballroom B |
| Adaptive Designs in Drug Development - Contributed - Papers | ||
|
Biopharmaceutical Section, Biometrics Section |
||
| Chair(s): Kimberly Crimin, Wyeth | ||
| 2:05 PM |
Findings from Simulation Studies on Treatment (Trt) Switching in Clinical Trial (CT) —  Dachuang Cao, Eli Lilly and Company; Hongmei Jiang, Northwestern University,
|
|
| 2:20 PM |
Adaptive Design with Continuous Responses and Binary Utility — Yuehui Wu, GlaxoSmithKline; Valeri V. Fedorov, GlaxoSmithKline
|
|
| 2:35 PM |
Midcourse Selection of the Primary Endpoint in Clinical Trials — Zhilong Yuan, Johnson & Johnson PRD; Yang Song, Johnson & Johnson PRD; Xiaolong Luo, Johnson & Johnson PRD; George Chi, Johnson & Johnson PRD
|
|
| 2:50 PM |
On Treatment Selection in Accelerated Drug Development — Ying Wan, Temple University; Keaven M. Anderson, Merck & Co., Inc.; Cong Chen, Merck & Co., Inc.; Boris Iglewicz, Temple University
|
|
| 3:05 PM |
Adaptive Treatment Selection in Seamless Phase II/III Designs — Xiaoling Wu, Bristol-Myers Squibb Company
|
|
| 3:20 PM |
Adaptive Design and Decision Analysis: Companions for Transforming Clinical Development — Andreas Sashegyi, Eli Lilly and Company
|
|
| 3:35 PM |
Unweighted versus Weighted Adaptive Design and Its Application in COPD Clinical Trials — Peter Zhang, Otsuka Pharmaceutical Development & Commercialization, Inc.
|
|
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |